alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
### IN THE TENTH COURT OF APPEALS
No. 10
- 11
- 00232
- CR JAMIE LEE HEWETT , Appellant v. THE STATE OF TEXAS , Appellee

From the 220th District Court Bosque County, Texas Trial Court No. 11
- 02
- 14500
- BCCR

MEMORANDUM OPINION

Jamie Lee Hewett was found guilty of the state

- jail felony offense of evading arrest in a motor vehicle and was assessed a twenty

- four months’ sentence in state jail and a $1,000 fine. Hewett appealed. Hewett’s appointed appellate counsel has filed a motion to withdraw and an Anders brief , asserting that he has diligently reviewed the appellate record and that, in his opinion, the appeal is frivolous. See Anders v. California , 386 U.S. 738, 87 S. Ct. 1396,
18 L.Ed. 2d 493 (1967)

. Although informed of his right to do so, Hewett did not file a proHewett v. State Page 2

se response to the Anders brief.
In an Anders case, we must, “after a full examination of all the proceedings,

... decide whether the case is wholly frivolous.” Id. at 744, 87 S. Ct. at 1400 ; accord Stafford v.
State , 813 S.W.2d 503, 509

- 11 (Tex. Crim. App. 1991)

. An appeal is “wholly frivolous” or “without merit” when it “lacks any basis in law or fact.” McCoy v. Court of Appeals , 486 U.S. 429, 439 n.10, 108 S.Ct. 1895, 1902 n.10, 100 L.Ed.2d 440 (1988)

. We have conducted an independent review of the record, and because we find this appeal to be wholly
frivolous , w e affirm the judgment. We grant appointed c ounsel ’ s amended motion to withdraw from representation
of Hewett. Notwithstanding this grant, appointed counsel must send Hewett a copy of our decision, notify him of his right to file a pro se petition for discretionary review, and
send this Court a letter cer tifying counsel ’ s compliance with Texas Rule of Appellate
Procedure 48.4. T EX
. R. A PP
. P . 48.4; see also Ex parte Owens , 206 S.W.3d 670, 673

- 74 (Tex. Crim. App. 2006)

.

REX D. DAVIS Justice Before Chief Justice Gray, Justice Davis , and Justice Scoggins Affirmed Opini on delivered and filed April 25, 2012 Do n ot p ublish [CR25]
[Federal Register Volume 74, Number 95 (Tuesday, May 19, 2009)]
[Notices]
[Page 23423]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-11601]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): CDC Grants for Public Health Research 
Dissertation, Panel K, Funding Opportunity Announcement (FOA) PAR07-
231, Initial Review

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting.

    Time and Date: 10 a.m.-12 p.m., June 4, 2009 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in section 552b(c) (4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in 
response to ``CDC Grants for Public Health Research Dissertation, 
Panel K, FOA PAR07-231.''
    Contact Person for More Information: Susan B. Stanton, D.D.S., 
Scientific Review Officer, Office of the Director, Office of the 
Chief Science Officer, CDC, 1600 Clifton Road, NE., Mailstop D72, 
Atlanta, GA 30333, Telephone: (404) 639-4640.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: May 13, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. E9-11601 Filed 5-18-09; 8:45 am]
BILLING CODE 4163-18-P
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          APR-30-1999
<PERIOD-END>                               OCT-31-1998
<CASH>                                         101,361
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               101,361
<PP&E>                                           6,038
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 107,399
<CURRENT-LIABILITIES>                            3,794
<BONDS>                                              0
<COMMON>                                       137,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                    (33,395)
<TOTAL-LIABILITY-AND-EQUITY>                   107,399
<SALES>                                              0
<TOTAL-REVENUES>                                22,259
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                 (9,714)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                             (9,714)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    (9,714)
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
##### 



Exhibit 99.3 CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Quarterly Report of Extendicare Inc. (the Company) on
Form 6-K for the period ending June 30, 2004 (the Report) each of the
undersigned officers of the Company certify solely for purposes of complying
with 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that:  (1)
    
    the Report fully complies with the requirements of section 13(a) or 15(d)
of the Securities Exchange Act of 1934; and  (2)
    
    the information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company. /s/ Mel RhinelanderMel RhinelanderPresident and Chief Executive OfficerAugust 12, 2004
 /s/ Mark W. DurishanMark W. DurishanVice President, Finance and Chief Financial OfficerAugust 12, 2004
 A signed original of this written statement required by Section 906 has been
provided to Extendicare Inc. and will be retained by the Company and furnished
to the Securities and Exchange Commission or its staff upon request.
#### UNITED STATES of America, Plaintiff-Appellee, v. THO DONG PHAN, Defendant-Appellant.

No. 06-30114.

United States Court of Appeals, Ninth Circuit.

Submitted Oct. 16, 2006.*

Filed Oct. 20, 2006.

Michael Dion, Esq., USTA-Office of the U.S. Attorney, Tacoma, WA, for Plaintiff-Appellee.

Colin Fieman, Esq., FPDWA-Federal Public Defender’s Office, Tacoma, WA, for Defendant-Appellant.

Before: T.G. NELSON, W. FLETCHER, and RAWLINSON, Circuit Judges.

*

 This panel unanimously finds this case suitable for decision without oral argument. See Fed. R.App. P. 34(a)(2).

MEMORANDUM **

Tho Dong Phan appeals from his guilty-plea conviction and 120-month sentence for possession of methylenedioxymeth-amphetamine with intent to distribute, in violation of 21 U.S.C. § 841(a)(1), (b)(1)(C).

Pursuant to *Anders v. California,*386 U.S. 738, 87 S.Ct. 1396, 18 L.Ed.2d 493 (1967), counsel for Phan has filed a brief stating that he finds no grounds for relief, along with a motion to withdraw as counsel of record. No pro se supplemental brief or answering brief has been filed.

Our examination of the brief and our independent review of the record pursuant to *Penson v. Ohio,*488 U.S. 75, 82-83, 109 S.Ct. 346, 102 L.Ed.2d 300 (1988), disclose no grounds for relief on direct appeal. Accordingly, we affirm the district court’s judgment.

Counsel’s motion to withdraw is GRANTED, and the district court’s judgment is AFFIRMED.

**

 This disposition is not appropriate for publication and may not be cited to or by the courts of this circuit except as provided by 9th Cir. R. 36-3.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health 

                    Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.                           ( print page 4046)    

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. 

*Name of Committee:*                         National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Mechanism of Immunological Tolerance.                     

*Date:*                         February 19, 2009.                     

*Time:*                         10 a.m. to 1 p.m.                     

*Agenda:*                         To review and evaluate grant applications.                     

*Place:*                         National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817.                     

*Contact Person:*                         Cheryl K. Lapham, PhD, Scientific Review Administrator, Scientific Review Program, DEA,  NIAID/NIH/DHHS,  6700-B Rockledge Drive,  MSC 7616, Room 3127,  Bethesda, MD 20892-7616,  301-402-4598,                         *clapham@niaid.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

                        Dated:                         *January 13, 2009.*

Jennifer Spaeth, 

Director, Office of Federal Advisory Committee Policy.

[FR Doc. E9-1156 Filed 1-21-09; 8:45 am] 

BILLING CODE 4140-01-P
##### 



SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
  FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934  Date of report (Date of earliest event reported): July 19, 2005 Inco Limited  Canada
    
    1-1143
    
    98-0000676(State or other jurisdiction
    
    (Commission
    
    (I.R.S. Employerof incorporation or organization)
    
    file number)
    
    Identification Number)
 145 King Street West, Suite 1500
Toronto, Ontario M5H 4B7
(Address of Principal Executive Offices) Companys telephone number, including area code: (416) 361-7511 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions:  o
    
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)o
    
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)o
    
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))o
    
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))




---



##### 



Item 5.02.
    
    Departure of Directors or Principal Officers; Election of Directors;
Appointment of Principal Officers
  (b)
    
    As previously indicated in the Proxy Circular and Statement covering the Annual
and Special Meeting of Shareholders of Inco Limited (the Company) held on April 20,
2005, James M. Stanford, a Director of the Company, elected to retire from his position
as a Director after the Companys meeting of its Board of Directors on July 19, 2005;(d)
    
    (1)     As reflected in the press release issued by the Company on July 19, 2005 filed as an
Exhibit to this Report, at a meeting of the Companys Board of Directors held the
evening of July 18, 2005, Richard (Rick) Waugh and Francis Mer were appointed Directors
of the Company;(3)     Neither Messrs. Waugh nor Mer was appointed to any committee of the Companys
Board of Directors in conjunction with their appointment as Directors by the Companys
Board of Directors the evening of July 18, 2005. It is currently expected that Mr.
Waugh will be appointed to the Boards Management Resources and Compensation and
Pension Committees and Mr. Mer will be appointed to the Boards Audit and Capital
Projects Committees.




---



##### 



SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. INCO LIMITEDBy:
    /s/ Stuart F. FeinerStuart F. FeinerExecutive Vice-President
General Counsel and Secretary Date: July 19, 2005




---



##### 



EXHIBIT INDEX Exhibit No.
    
    Description of Exhibit
    
    Page(1)
    
    Exhibit 99(99.1)     Inco Limited press release dated July 19, 2005.
<PAGE>   1
                                                                      EXHIBIT 11


                 STATEMENT OF COMPUTATION OF PER SHARE EARNINGS

<TABLE>
<CAPTION>
                                                                                                  Three months ended March 31
                                                                                                  ----------------------------
                                                                                                      1995             1996
                                                                                                  -----------       ----------
                                                                                                                  (as restated)
                          <S>                                                                     <C>                <C>
                          Actual Weighted Average Shares Outstanding for the Period               5,411,815          6,244,673

                          Dilutive Effects of Stock Options and Warrants Using Average
                            Market Price                                                            499,136            268,608
                                                                                                  ---------         ----------

                          Total Shares Based on Shares Outstanding and the Assumption that
                            All Share Equivalents Are Exercised at Average Stock Market
                            Price.                                                                5,910,951          6,513,281

                          Additional Dilutive Effect of Stock Options and Warrants Being
                            Exercised Using Ending Market Price                                          --                 --    
                                                                                                 ----------         ----------

                          Total Shares Based on Shares Outstanding and the   Assumption
                            That All Stock Options and Warrants are Exercised at Ending
                            Market Price                                                          5,910,951          6,513,281
                                                                                                 ==========         ==========


                          Net Income Applicable to Fully Diluted Earnings Per Share              $  397,494         $  206,912
                                                                                                 ==========         ==========


                          Fully Diluted Net Income Per Share                                     $      .07         $      .03
                                                                                                 ==========         ==========
</TABLE>
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of State

          - [Public Notice 6619]

Based upon a review of the Administrative Records assembled in this matter pursuant to Section 219(a)(4)(C) of the Immigration and Nationality Act, as amended (8 U.S.C. 1189(a)(4)(C)) (“INA”), and in consultation with the Attorney General and the Secretary of the Treasury, I conclude that the circumstances that were the basis for the 2003 re-designation of Revolutionary Nuclei as a foreign terrorist organization have changed in such a manner as to warrant a revocation of the designation.

Therefore, I hereby revoke the designation of the aforementioned organization as a foreign terrorist organization, pursuant to Section 219 of the INA (8 U.S.C. 1189).

                    This determination shall be published in the                     **Federal Register.**

Dated: April 29, 2009.

Hillary Rodham Clinton,

Secretary of State, Department of State.

[FR Doc. E9-11549 Filed 5-15-09; 8:45 am]

BILLING CODE 4710-10-P
exv10w19



 





Exhibit 10.19



AMENDMENT TO EMPLOYMENT AGREEMENT



This Amendment dated this 8th day of March, 2004, covers the
Employment Agreement dated October 24, 1994 between
Edelbrock Corporation, a Delaware corporation
(“Edelbrock”), Edelbrock Foundry Corp., a California
corporation (“Edelbrock Foundry”) and O. Victor
Edelbrock Jr. (“Employee”).



Section 3.     Term and Termination



			
	 	3.1	
    Employee’s term of employment shall be amended to cover the
    period July 1, 2004 through June 30, 2009.





All other provisions of the October 24, 1994 Agreement
shall remain unchanged and be in full force and effect.



EMPLOYEE



/s/ O. Victor Edelbrock Jr.











O. Victor Edelbrock Jr.




EDELBROCK CORPORATION



		
	By: 	
    /s/ O. Victor Edelbrock Jr.










		
	Its: 	
    President and C.E.O.










EDELBROCK FOUNDRY CORP.



		
	By: 	
    /s/ O. Victor Edelbrock Jr.










		
	Its: 	
    President and C.E.O.
<PAGE>

                                 HOLLINGER INC.
                 INDEPENDENT DIRECTORS SEEK GUIDANCE FROM COURT

Toronto, Ontario, Canada, February 28, 2005 -- Hollinger Inc. ("Hollinger")
(TSX: HLG.C; HLG.PR.B) announced that the independent members of its Board of
Directors had applied to Justice Colin Campbell of the Ontario Superior Court of
Justice for:

o    advice and directions whether in all the circumstances a proposed share
     consolidation "Going Private Transaction" should be put to a vote by
     minority public shareholders of Hollinger before an Inspector's Report is
     available from Ernst & Young LLP dealing with related party transactions;

o    an order approving an increase of $10 million to the indemnity fund to
     provide the five independent directors with a realistic measure of
     protection against the costs of potential and threatened litigation;

o    an order approving setting aside $500,000 as an indemnity fund to provide
     two Hollinger financial executives with protection against the costs of
     potential litigation; and

o    an order relating to the retention of the independent directors and certain
     related compensation and indemnification matters.

The application has been made because of matters arising as a result of
Hollinger recently having given notice to Canadian securities regulators of a
proposed special meeting of shareholders that would be held on March 31, 2005 to
consider the proposed Going Private Transaction which was originally announced
on October 28, 2004. Notice of the meeting must be sent to shareholders no later
than March 10, 2005. The directors have been advised by the Inspector that the
Inspector's Report will not be available by that date or by March 31, 2005.

Hollinger's principal asset is its interest in Hollinger International Inc.
which is a newspaper publisher, the assets of which include the Chicago
Sun-Times, a large number of community newspapers in the Chicago area and a
number of news media investments, as well as a portfolio of revenue-producing
and other commercial real estate in Canada, including its head office building
located at 10 Toronto Street, Toronto, Ontario.


Media contact:
Larry Parnell
Hill & Knowlton
416-413-4623
larry.parnell@hillandknowlton.ca


                              www.hollingerinc.com